Institutions / MPM BioImpact LLC / Holdings
Back to MPM BioImpact LLC

MPM BioImpact LLC

All holdings · as of Dec 31, 2025

38 positions

CompanyClassValue ↓Shares% of portfolio
Cullinan Therapeutics, Inc.—$79.16M7,648,2689.1%
MADRIGAL PHARMACEUTICALS, INC.—$56.36M96,7806.4%
Liquidia CorpLQDACommon Stock$48.32M1,400,8695.5%
Trevi Therapeutics, Inc.—$41.15M3,287,0874.7%
Edgewise Therapeutics, Inc.—$41.08M1,655,2564.7%
Revolution Medicines, Inc.—$40.28M505,6724.6%
AGIOS PHARMACEUTICALS, INC.—$35.48M1,303,3734.1%
Uniqure NV—$33.06M1,381,6283.8%
PTC Therapeutics Inc—$32.66M430,0133.7%
Syndax Pharmaceuticals Inc—$28.11M1,337,7023.2%
Dyne Therapeutics, Inc.—$27.49M1,405,3883.1%
TARSUS PHARMACEUTICALS, INC.—$26.93M328,8693.1%
Stoke Therapeutics, Inc.—$24.45M770,2892.8%
ALUMIS INC.ALMSCommon Stock$23.44M2,401,9922.7%
Urogen Pharma Ltd—$22.05M941,3782.5%
Xenon Pharmaceuticals Inc.—$21.77M485,6202.5%
PALVELLA THERAPEUTICS, INC.PVLACommon Stock$21.54M205,7452.5%
Natera, Inc.—$21.43M93,5512.5%
Corvus Pharmaceuticals, Inc.—$21.13M2,743,6712.4%
DBV TECHNOLOGIES S.A.DBVTADR$19.11M996,8252.2%
Relay Therapeutics, Inc.—$18.89M2,232,4512.2%
Monte Rosa Therapeutics, Inc.—$18.40M1,173,3762.1%
BRIGHT MINDS BIOSCIENCES INC.—$17.96M230,1472.1%
PROTAGONIST THERAPEUTICS INC—$17.42M199,4712.0%
enGene Therapeutics Inc.—$16.62M1,840,8981.9%
Context Therapeutics Inc.—$15.70M10,679,3911.8%
Arcutis Biotherapeutics, Inc.—$15.43M531,2001.8%
Ventyx Biosciences, Inc.—$14.80M1,639,0611.7%
Oric Pharmaceuticals, Inc.—$14.71M1,798,7171.7%
BELITE BIO, INCBLTEADR$14.04M87,7601.6%
RAPT Therapeutics Inc—$13.48M397,9061.5%
Climb Bio, Inc.CLYMCommon Stock$10.69M2,671,4801.2%
Abivax SA—$7.59M56,3160.9%
ROCKET PHARMACEUTICALS, INC.—$5.57M1,586,0760.6%
Maze Therapeutics, Inc.—$3.36M81,1450.4%
Evommune, Inc.EVMNCommon Stock$1.93M113,0220.2%
Sarepta Therapeutics, Inc.—$1.51M70,0000.2%
Werewolf Therapeutics, Inc.HOWLCommon Stock$883.5K1,393,5570.1%
← PrevPage 1 of 1Next →